A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington. The lawsuit by GenBioPro Inc., filed Wednesday in federal court in Maryland, comes as the U.S. Supreme Court delayed until Friday a decision on which restrictions on the pill will remain in place after a federal judge in Texas blocked the FDA’s approval of mifepristone in a separate lawsuit. GenBioPro makes most of the mifepristone sold in the U.S.